Work Package 3
Follow a manual added link
The Evaluation WP ensures the quality, relevance and effectiveness of the Joint Action by monitoring risks and assessing progress towards the achievement of its objectives, including the relevance and quality of the deliverables.
It evaluates the pilots and use cases implemented in WP5, 6, 7, and 8., with a particular focus on the potential for secondary use of data and users’ experiences. As part of its efforts, it also assesses the preparedness of cancer centres for participation in HealthData@EU.
Leaders: Maria Sklodowska-Curie National Research Institute of Oncology (MSCI) and Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO)
PUBLIC MILESTONES AND DELIVERABLES
Task 3.1 (Milestone 14)
This evaluation plan outlines the approach for assessing the implementation and results of the eCAN Plus Joint Action at the project level. The evaluation focuses on a set of interlinked interventions contributing to the overall objectives of the Joint Action and is designed to support both continuous improvement and accountability.
WP3's Deliverables & Milestones
Interim Evaluation Report
The interim evaluation is a document that confirms successful implementation of the eCAN Joint Action (JA) mid-project. Almost all milestones and deliverables planned for the first year have been achieved. Delayed milestones and deliverables have no impact on project implementation.
Final Evaluation Report
This document reports on the evaluation of the eCAN JA. As part of the monitoring and evaluation task, coordinated by WP3, this report evaluates the achievement of the project’s objectives through Key Performance Indicators (KPIs); the risks, challenges and mitigation strategies identified and developed during the project’s life and the overall satisfaction with the project among participants.